舌下神经刺激治疗脑性瘫痪患者阻塞性睡眠呼吸暂停
本文报告一例28岁男性脑性瘫痪患者,合并神经肌肉畸形、近端交界性后凸和发育迟缓,表现为重度阻塞性睡眠呼吸暂停,对CPAP和BiPAP不耐受。植入舌下神经刺激器后,睡眠研究显示在2.4 V下通气和氧合改善,AHI从基线112次/小时降至12次/小时,仅遗留轻度间歇性打鼾;家属报告使用率较既往CPAP提高。作者认为舌下神经刺激可成为该人群OSA安全有效的治疗方式。
要点
- 脑性瘫痪患者因明显肌张力低下易合并阻塞性睡眠呼吸暂停。
- 本例重度OSA患者对CPAP和BiPAP不耐受,植入HGNS后AHI从112降至12次/小时。
- 作者认为HGNS可成为该人群OSA安全有效的治疗方式。
核心结论
- 作者认为舌下神经刺激可成为脑性瘫痪患者阻塞性睡眠呼吸暂停安全有效的治疗方式。
研究设计与样本
- 病例报告及文献复习,报告一例28岁男性脑性瘫痪患者。
主要发现
- 患者合并神经肌肉畸形、近端交界性后凸和发育迟缓,表现为重度阻塞性睡眠呼吸暂停,对CPAP和BiPAP不耐受。
- 植入舌下神经刺激器后睡眠研究显示在2.4 V下通气和氧合改善。
- AHI从基线112次/小时降至12次/小时,仅遗留轻度间歇性打鼾。
- 家属报告使用率较既往CPAP提高。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Obstructive sleep apnea (OSA) is common amongst patients with cerebral palsy in part due to significant hypotonia. Hypoglossal nerve stimulation (HGNS) is a novel tool used to treat sleep apnea when there is failure with CPAP. To our knowledge, the literature has not discussed HGNS as a treatment option for severe OSA in patients with cerebral palsy. METHODS: Case report and literature review. RESULTS: A 28-year-old male with cerebral palsy, neuromuscular deformity, proximal junction kyphosis, and developmental delay presented with severe obstructive sleep apnea and was intolerant to CPAP and BiPAP. After HGNS implantation, a sleep study revealed improved ventilation and oxygenation at 2.4 V; AHI decreased from baseline of 112 to 12 events per hour with only mild intermittent snoring. The patient's family reported increased utilization compared with previous CPAP use. CONCLUSION: HGNS can be a safe and effective treatment modality for OSA in this patient population. Laryngoscope, 134:2478-2479, 2024.
引用
- Scheffler P, Eitan D, Drewek R, et al. Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea in a Patient with Cerebral Palsy. Laryngoscope. 2023. PMID: 37882417. doi:10.1002/lary.31128
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。